Research on PDA has shown that honokiol interferes with oncogenic signaling networks—namely STAT3 and NF-κB—thereby inhibiting tumor cell proliferation and enhancing apoptosis [188]. This evidence concerns the gene NFKB1 and Patent ductus arteriosus.